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Abstract
Cardiac failure is an uncommon complication of juvenile hyperthyroidism. We describe an adolescent boy with
Graves’ disease who developed manifestations of heart failure while on antithyroid medications. There was no
evidence of any underlying cardiac disease. He had paradoxical euthyroid hormone profile which rose to
hyperthyroid range when the manifestations of the cardiac failure subsided. The case highlights several unusual
features of Graves’ disease.
Introduction
Thyroid hormones have multiple effects on the cardiovas-
cular system [1]. Although many of the characteristic signs
and symptoms of hyperthyroidism are cardiovascular, car-
diac failure is seen only in up to 6% cases [2] and is more
common in older age with underlying ischemic or hyper-
tensive cardiomyopathy [1,2]. There are very few reports
in the literature of cardiac failure in juvenile hyperthyroid-
ism in the absence of underlying heart disease [3].
A state of cardiac failure is known to cause changes in
t h et h y r o i dh o r m o n ep r o f i l e ,e s p e c i a l l yl o wt o t a lt r i -
iodothyronine (T3) [4,5]. This phenomenon of non-
thyroidal illness syndrome (NTIS) may be attributable
to various mechanisms including changes in hypothala-
mic-pituitary axis, altered thyroid hormone binding and
altered de-iodinase activity [6]. The same phenomenon
has not been well documented in cardiac failure due to
hyperthyroidism.
Herein we describe an adolescent boy who presented
in cardiac failure due to Graves’ disease and had a para-
doxical euthyroid profile.
Case Report
A 13 year old boy presented with palpitations of six
months duration, fever and hyperdefecation for a month
and generalized edema since three days. Fatigue, diaphor-
esis, tremors, polyphagia and weight loss were present for
six months. He was diagnosed to have hyperthyroidism
five months before presentation to us. He was started on
carbimazole 15 mg daily at the time of diagnosis, which
was increased to 45 mg daily one week prior to presenta-
tion at our hospital.
On examination, the patient was febrile with a heart rate
of 130 per minute and a blood pressure of 140/60 mm Hg.
There was generalized edema and raised JVP (12 cm of
water). He had exophthalamos. The thyroid gland was dif-
fusely enlarged to approximately 60 grams and a bruit was
heard over the thyroid. Cardiomegaly was present as well
as a grade 3/6 apical ejection systolic murmur. There was
mild weakness (grade 4 power) of hips, knees and
shoulders, with hyperreflexia. Hepatosplenomegaly was
present. Hemoglobin was 96 g/L (normal, 130-160 g/L),
total leukocytes 4.1 × 10
9/L (normal, 4.5-13.5 × 10
9/L),
and platelets 51 × 10
9/L (normal, 150-400 × 10
9/L). He
had hyponatremia (serum Na 121 mEq/L; normal,135-145
mEq/L) and hypoalbuminemia (serum albumin 25 g/L;
normal, 35-55 g/L). Blood and urine cultures, Widal test
and smear for malarial parasite were negative. The ECG
showed sinus tachycardia, normal QRS voltages and T
wave inversion in precordial leads V2-V6. The chest radio-
graph was normal except for mild cardiomegaly (cardi-
othoracic ratio 54%). The echocardiogram showed mild
pulmonary arterial hypertension, dilated right ventricle
and tricuspid regurgitation with normal contractility of
both the ventricles. There was no evidence of underlying
congenital or acquired heart disease.
Thyroid function tests revealed low T3 (0.77 nmol/L;
normal, 1.3-2.8 nmol/L), normal total T4 (104.1 nmol/L;
normal, 60-160 nmol/L) and free T4 (22.6 pmol/L; nor-
mal, 10-25 pmol/L) with a suppressed TSH (<0.15 mU/L;
* Correspondence: gjevalikar@gmail.com
1Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of
Medical Sciences, Raebareli Road, Lucknow (U.P.), 226 014, India
Full list of author information is available at the end of the article
Jevalikar et al. International Journal of Pediatric Endocrinology 2011, 2011:8
http://www.ijpeonline.com/content/2011/1/8
© 2011 Jevalikar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.normal, 0.3-5 mIU/L). Thyrotropin receptor antibody
titer was 28.5 IU/L by ELISA (normal, <1.5 IU/L).
In addition to the supportive care, the patient was
started on prednisolone 60 mg/day, propranolol 40 mg/
day and carbimazole was continued. After three days of
treatment, the signs of heart failure subsided; however,
fever and tachycardia were persistent. Repeat T4 and free
T4 now rose to hyperthyroid levels (Table 1), with serum
albumin of 31 g/L. He was given potassium iodide drops
for further symptomatic improvement. During the hospital
stay he developed hyperglycemia probably caused by the
combined effect of hyperthyroidism and glucocorticoid
therapy, requiring insulin for two weeks.
After three days of starting potassium iodide, the fever
subsided and there was significant improvement in signs
of thyrotoxicosis. The steroids and potassium iodide
were tapered and omitted sequentially. Thyroid hormone
levels gradually normalized after four weeks of treatment.
A repeat echocardiogram showed mild mitral and tricus-
pid regurgitation, normal left ventricular contractility and
right ventricular systolic pressure of 33 mm Hg (normal,
<30 mm of Hg) suggestive of mild pulmonary
hypertension.
Because of severe presentation and poor access to
medical assistance from his native place, he was sub-
jected to radio-iodine ablation after two months of pre-
sentation to us, with 10 mCi of radioactive I
131.T h e
thyroid scan done at this time revealed diffuse increase
in tracer uptake. In subsequent follow up he was diag-
nosed to have radio-iodine induced hypothyroidism
requiring thyroxine replacement (Table 1).
Discussion
Hyperthyroidism has multiple effects on the cardiovas-
cular system including decreased systemic vascular resis-
tance and increased resting heart rate, left ventricular
contractility and blood volume leading to a state of high
cardiac output [1]. A small percentage of patients with
hyperthyroidism may present with clinical manifesta-
tions of cardiac failure [2].
Our patient was admitted with signs and symptoms
suggestive of hyperthyroidism and cardiac failure. There
was no evidence of underlying heart disease on clinical
examination and echocardiography. The chest X-ray and
ECG findings did not suggest primary pulmonary pathol-
ogy or viral myocarditis. In a study of 591 adults with
hyperthyroidism, heart failure was reported in 5.8% cases
[2]. Atrial fibrillation increases the risk of cardiac failure
but it can also occur in sinus rhythm [7]. There are very
few reports of cardiac failure in juvenile hyperthyroidism.
In a retrospective analysis of 21 children with hyperthyr-
oidism, cardiac failure was observed in 2 patients [3].
There is some evidence of presence of thyrotoxic cardio-
myopathy in children [8].
In our patient, in the presence of normal left ventricu-
lar contractility, edema, raised JVP and hepatomegaly
could be attributed to the pulmonary hypertension and
right ventricular failure. In contrast to the fall in systemic
vascular resistance, pulmonary arterial hypertension has
been reported in as many as 47% of patients with
hyperthyroidism [9]. The various underlying mechanisms
are related to increased venous return due to increased
blood volume, high output or autoimmune pulmonary
endothelial injury or increased metabolism of certain
vasodilator substances [10]. The increased blood volume
(postulated to occur as a result of activation of renin-
angiotensin-aldosterone system and increased red cell
mass) causes volume overload of the right ventricle,
which when unaccompanied by fall in pulmonary vascu-
lar resistance, leads to right ventricular failure and sys-
temic venous congestion [10,11].
The thyroid hormone profile of the patient revealed low
T3 and paradoxically normal total and free T4. The hor-
mones rose to hyperthyroid levels when the cardiac failure
subsided. This can be explained by mechanisms similar to
those causing thyroid function abnormalities in non-thyroi-
dal illnesses, also known as sick euthyroid syndrome. It is a
well known phenomenon in various diseases including car-
diac failure [4,5]. The various underlying mechanisms
include impaired hypothalamic TRH secretion, decreased
binding proteins, decreased de-iodinase activity, presence
of inhibitors of thyroid hormone binding, impaired tissue
uptake and altered receptor expression [6]. The most com-
mon manifestation of this is a low T3. However, low T4
can also be seen in severe or prolonged illness [12].
Another reason for lower than expected T3 and T4 in our
case could be the low albumin levels. Per se albumin has lit-
tle influence on hormone levels, unless associated with
changes in thyroglobulin and transthyretin. As all three are
synthesized in liver, albumin level may serve as a surrogate
marker for thyroglobulin [13]. Free T4 results in non thyr-
oidal illness are variable and are dependent on the assay
method used [6]. In our case the free T4 was measured by
a solid phase radioimmunoassay and equilibrium dialysis
method was not used. Free T3 measurements have been
shown to have a modest decline in levels, however reliable
estimation of free T3 is difficult [6].
The phenomenon similar to sick euthyroid syndrome in
hyperthyroidism has been previously documented in rela-
tion to myocardial infarction, diabetic ketoacidosis, pneu-
monia and fulminant hepatitis [14]. However to the best
of our knowledge this is the first report of this phenom-
enon in cardiac failure due to juvenile hyperthyroidism.
In addition to non thyroidal illness, other factors like
prior use of carbimazole and concurrent iodine defi-
ciency can influence the results of the thyroid function.
Patients with hyperthyroidism on carbimazole therapy
tend to normalize T4 ahead of T3, the latter being a
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Page 2 of 4Table 1 Serial thyroid functions, clinical features and treatment
Day T4 (60-160 nmol/L) Free T4 (10-25 pmol/L) T3 (1.3-2.8 nmol/L) TSH (0.3-5 mIU/L) Albumin (35-55 g/L) Clinical event Treatment
1 104.8 22.6 0.7 <0.15 25 CHF* Carbimazole Prednisolone
Propranolol
4 205.3 58.0 1.7 31 Resolution of CHF*




12 1.0 Fever resolved Steroid tapering started
4 week 80.8 36 Off KI
† and steroids
9 week 35.0 Clinically hypothyroid Carbimazole dose reduced
RaIA
¶ done
4 month 119.8 <0.15 49 Clinically euthyroid
9 month** <12.9 >60 Radiation induce
Hypothyroidism
Thyroxine started
*CHF: congestive heart failure,
† KI: Potassium iodide,
¶ RaIA: Radioactive Iodine Ablation























































































































4better indicator of the clinical status. Hence, some
patients may have normal T4 despite being clinically
hyperthyroid [15]. However, T3 is usually high in such
cases (isolated T3 toxicosis). The presence of low T3 and
t h er i s eo fT 4a n df r e eT 4t oh y p e r t h y r o i dr a n g eo nt h e
same dose of carbimazole ruled out this possibility in our
patient.
T h ef i n d i n go fn o r m a lT 4m a ya l s ob es e e ni n
hyperthyroidism with co-existing iodine deficiency [16].
These patients have higher frequency of isolated T3 tox-
icosis. Since our patient consumed iodized salt, this
mechanism was not invoked to explain the lower than
expected T4.
The severity of the case required the use of glucocorti-
coids and potassium iodide for control of the symptoms.
Glucocorticoids reduce de-iodination of T4 to T3. In addi-
tion, T4 secretion may be reduced due to direct thyroidal
action and reduced thyroid stimulating antibodies [17].
Potassium iodide rapidly reduces the release of T4 and T3
from the thyroid gland and suppresses iodide oxidation and
organification. When used for short term, it is useful for
rapid symptomatic relief. To avoid stimulation of thyroid
hormone synthesis, iodide should be given not earlier than
60 minutes after the start of the anti-thyroid medication
[18].
Some other less common features of Graves’ disease
noted in this case were leukopenia, thrombocytopenia
[19], splenomegaly [20] and persistent fever [21].
Key Messages
￿ Congestive cardiac failure occurring in the absence
of atrial fibrillation or underlying heart disease is a rare
manifestation of hyperthyroidism.
￿ Occurrence of cardiac failure in hyperthyroidism may
be associated with a paradoxically euthyroid hormone pro-
file due to the phenomenon of sick euthyroid syndrome.
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